A synergic action of colistin, imipenem, and silver nanoparticles against pandrug-resistant Acinetobacter baumannii isolated from patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A synergic action of colistin, imipenem, and silver nanoparticles against pandrug-resistant Acinetobacter baumannii isolated from patients
Authors
Keywords
Pandrug-resistant, A. baumannii, Synergy, MIC, FIC index, Colistin, Silver nanoparticles, Imipenem
Journal
Journal of Infection and Public Health
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-09-24
DOI
10.1016/j.jiph.2021.09.015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Key Takeaways From the U.S. CDC’s 2019 Antibiotic Resistance Threats Report for Frontline Providers
- (2020) Sameer S. Kadri CRITICAL CARE MEDICINE
- The Antibacterial Mechanism of Silver Nanoparticles and Its Application in Dentistry
- (2020) Iris Xiaoxue Yin et al. International Journal of Nanomedicine
- Combined Strategy for Post-Operative Patients with Central Nervous System Infections Caused by Extensively Drug-Resistant/Pan-Drug–Resistant Acinetobacter baumannii: A Retrospective Study
- (2020) Jian-bo Chang et al. Surgical Infections
- Development and Validation of a Model for Predicting the Risk of Death in Patients with Acinetobacter baumannii Infection: A Retrospective Study
- (2020) Hui Zhang et al. Infection and Drug Resistance
- Synergistic Antibacterial Activity of Combined Antimicrobials and the Clinical Outcome of Patients With Carbapenemase-Producing Acinetobacter baumannii Infection
- (2020) Junyan Qu et al. Frontiers in Microbiology
- Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii
- (2019) Yangang Zhou et al. BMC Pharmacology & Toxicology
- Synergistic Activities of Colistin Combinations with Meropenem, Sulbactam, Minocycline, Disodium Fosfomycin, or Vancomycin Against Different Clones of Carbapenem-Resistant Acinetobacter baumannii Strains
- (2019) Ahmet Sertcelik et al. Microbial Drug Resistance
- Analysis of Acinetobacter baumannii hospital infections in patients treated at the intensive care unit of the University Hospital, Wroclaw, Poland: a 6-year, single-center, retrospective study
- (2018) Wieslawa Duszynska et al. Infection and Drug Resistance
- Antimicrobial Activity of Selected Antimicrobial Peptides Against Planktonic Culture and Biofilm of Acinetobacter baumannii
- (2018) Maciej Jaśkiewicz et al. Probiotics and Antimicrobial Proteins
- Analysis of clinical and microbiological data on Acinetobacter baumannii strains assist the preauthorization of antibiotics at the patient level for an effective antibiotic stewardship program
- (2017) Khine Swe Swe-Han et al. Journal of Infection and Public Health
- Resistant mechanisms and molecular epidemiology of imipenem-resistant Acinetobacter baumannii
- (2016) Shu-Zhen Xiao et al. Molecular Medicine Reports
- Acinetobacter baumannii: evolution of a global pathogen
- (2013) Luísa C.S. Antunes et al. Pathogens and Disease
- Colistin: an update on the antibiotic of the 21st century
- (2012) Silpak Biswas et al. Expert Review of Anti-Infective Therapy
- Lipopolysaccharide-Deficient Acinetobacter baumannii Shows Altered Signaling through Host Toll-Like Receptors and Increased Susceptibility to the Host Antimicrobial Peptide LL-37
- (2012) Jennifer H. Moffatt et al. INFECTION AND IMMUNITY
- Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
- (2012) Y. Cai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Acinetobacter baumannii
- (2012) Aoife Howard et al. Virulence
- Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU
- (2011) Wang-Huei Sheng et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Synergy Testing by Etest, Microdilution Checkerboard, and Time-Kill Methods for Pan-Drug-Resistant Acinetobacter baumannii
- (2010) M. M. Sopirala et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
- (2010) J. H. Moffatt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment Options
- (2008) Lisa L. Maragakis et al. CLINICAL INFECTIOUS DISEASES
- Acinetobacter baumannii: Emergence of a Successful Pathogen
- (2008) A. Y. Peleg et al. CLINICAL MICROBIOLOGY REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now